Dova Pharmaceuticals, Inc.. (DOVA) NASDAQ

$28.04 - (-)

Market Cap: -

As of 11/11/19 04:00 PM EST. Market closed.

(DOVA)

Dova Pharmaceuticals, Inc.. (DOVA)
NASDAQ

$28.04
- (-)

Market Cap: -

As of 11/11/19 04:00 PM EST. Market closed.

Add to Portfolio

Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was ... read more

Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. read less

COMPANY PROFILE
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO Compensation (Base)
$10,417
CEO Compensation (Total)
$4.38M
URL
Address
.
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO Compensation (Base)
$10,417
CEO Compensation (Total)
$4.38M
Address
.
PRICE CHART FOR DOVA PHARMACEUTICALS, INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
$5.62 - $28.54
Volume
0
Avg. Volume (30 days)
501,889
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
-
Days Range
- - -
52 week range
$5.62 - $28.54
Volume
0
Avg. Volume (30 days)
501,889
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR DOVA PHARMACEUTICALS, INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR DOVA PHARMACEUTICALS, INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Stalfort SeanDirectorNov 12, 2019 Option Exercise$27.50635,66517,480,7880Nov 12, 2019, 04:40 PM
Manning Paul BDirectorNov 12, 2019 Option Exercise$27.501,783,22649,038,7150Nov 12, 2019, 04:38 PM
Manning Paul BDirectorNov 12, 2019 Option Exercise$27.5012,979,016356,922,9400Nov 12, 2019, 04:38 PM
ZACCARDELLI DAVIDPresident & CEOOct 01, 2019 Sale$27.905,275147,17276,647Oct 02, 2019, 04:21 PM
ALLEN LEE F MD PhDChief Medical OfficerSep 30, 2019 Sale$28.0097827,3849,635Oct 02, 2019, 04:21 PM
Hahn Mark WChief Financial OfficerSep 30, 2019 Sale$28.0077521,7009,024Oct 02, 2019, 04:20 PM
Hoitt JasonChief Commercial OfficerSep 30, 2019 Sale$28.002,38766,8369,970Oct 02, 2019, 04:20 PM
Laliberte KevinSr. VP, Product DevelopmentSep 30, 2019 Sale$28.003,696103,4885,357Oct 02, 2019, 04:20 PM
Laliberte KevinSr. VP, Product DevelopmentSep 25, 2019 Sale$20.003,10062,0008,457Sep 27, 2019, 04:05 PM
Manning Paul BDirectorAug 09, 2019 Buy$15.8728,062445,34412,979,016Aug 12, 2019, 04:15 PM
Laliberte KevinSr. VP, Product DevelopmentJul 31, 2019 Sale$15.971,38922,18211,557Aug 01, 2019, 04:31 PM
Hoitt JasonChief Commercial OfficerJul 15, 2019 Sale$15.267,580115,66413,257Jul 16, 2019, 04:29 PM
PERCEPTIVE ADVISORS LLC10% OwnerJul 09, 2019 Buy$16.6129,834495,5433,653,435Jul 11, 2019, 08:31 PM
PERCEPTIVE ADVISORS LLC10% OwnerJul 11, 2019 Buy$16.6742,916715,4103,708,705Jul 11, 2019, 08:31 PM
PERCEPTIVE ADVISORS LLC10% OwnerJul 10, 2019 Buy$16.8912,354208,6593,665,789Jul 11, 2019, 08:31 PM
PERCEPTIVE ADVISORS LLC10% OwnerJul 05, 2019 Buy$16.4650,000823,0003,632,601Jul 09, 2019, 07:43 PM
PERCEPTIVE ADVISORS LLC10% OwnerJul 03, 2019 Buy$16.671,70528,4223,573,601Jul 03, 2019, 08:28 PM
PERCEPTIVE ADVISORS LLC10% OwnerJul 02, 2019 Buy$16.1471511,5403,571,896Jul 03, 2019, 08:28 PM
PERCEPTIVE ADVISORS LLC10% OwnerJul 01, 2019 Buy$14.2418,121258,0433,571,181Jul 03, 2019, 08:28 PM
ZACCARDELLI DAVIDPresident & CEOJul 02, 2019 Sale$15.9410,450166,60886,473Jul 03, 2019, 04:24 PM
Hahn Mark WChief Financial OfficerJul 01, 2019 Sale$14.171,54521,8939,799Jul 02, 2019, 04:59 PM
JEFFS ROGERDirectorJul 01, 2019 Sale$14.171,30818,53466,993Jul 02, 2019, 04:58 PM
Laliberte KevinSr. VP, Product DevelopmentJul 01, 2019 Sale$14.171,19116,87612,946Jul 02, 2019, 04:57 PM
ALLEN LEE F MD PhDChief Medical OfficerJul 01, 2019 Sale$14.191,95727,77010,613Jul 02, 2019, 04:56 PM
Hoitt JasonChief Commercial OfficerJun 28, 2019 Sale$13.812,38732,96320,087Jul 02, 2019, 04:55 PM
PERCEPTIVE ADVISORS LLC10% OwnerJun 28, 2019 Buy$14.17100,0001,417,0853,553,060Jul 01, 2019, 07:23 PM
PERCEPTIVE ADVISORS LLC10% OwnerJun 27, 2019 Buy$13.10327,2094,286,1243,453,060Jul 01, 2019, 07:23 PM
Goldman Steven M.DirectorJun 26, 2019 Option Exercise$8.291,75014,511144,280Jun 27, 2019, 04:21 PM
Goldman Steven M.DirectorJun 20, 2019 Option Exercise$8.291,75014,509142,530Jun 24, 2019, 04:54 PM
Goldman Steven M.DirectorMay 13, 2019 Option Exercise$7.323,66826,850140,780Jun 03, 2019, 08:35 PM
Goldman Steven M.DirectorJan 02, 2019 Option Exercise$7.324,58333,548137,112Jun 03, 2019, 08:35 PM
Hoitt JasonChief Commercial OfficerApr 08, 2019 Sale$8.772,38720,93422,324Apr 10, 2019, 04:48 PM
Manning Paul BDirectorMar 07, 2019 Buy$7.4868,000508,64012,950,954Mar 08, 2019, 08:46 AM
JEFFS ROGERDirectorDec 20, 2018 Buy$6.251,1697,30661,400Dec 21, 2018, 05:12 PM
JEFFS ROGERDirectorDec 19, 2018 Buy$6.2228,831179,32960,231Dec 21, 2018, 05:12 PM
ZACCARDELLI DAVIDPresident & CEODec 20, 2018 Buy$6.0710,00060,70092,372Dec 21, 2018, 05:11 PM
Manning Paul BDirectorDec 21, 2018 Buy$6.48128,500832,05012,882,954Dec 21, 2018, 05:09 PM
Stalfort SeanDirectorDec 20, 2018 Buy$6.2631,000194,060635,665Dec 21, 2018, 05:07 PM
Hahn Mark WChief Financial OfficerDec 19, 2018 Buy$6.282,50015,7002,500Dec 21, 2018, 05:05 PM
Manning Paul BDirectorDec 20, 2018 Buy$6.17266,6311,645,11312,754,454Dec 20, 2018, 05:28 PM
Sapir AlexPresident & CEOAug 14, 2018 Buy$22.8321,700495,41121,700Aug 15, 2018, 04:27 PM
Goldman Steven M.DirectorAug 13, 2018 Option Exercise$7.321,83213,410125,001Aug 15, 2018, 07:46 AM
Goldman Steven M.DirectorJun 21, 2018 Buy$30.225,000151,100123,169Jun 25, 2018, 08:07 AM
PERCEPTIVE ADVISORS LLC10% OwnerJun 11, 2018 Buy$29.3619,700578,4243,125,851Jun 13, 2018, 04:10 PM
PERCEPTIVE ADVISORS LLC10% OwnerJun 08, 2018 Buy$28.6525,000716,2003,106,151Jun 12, 2018, 04:07 PM
PERCEPTIVE ADVISORS LLC10% OwnerJun 07, 2018 Buy$28.1850,0001,409,1543,081,151Jun 11, 2018, 04:37 PM
PERCEPTIVE ADVISORS LLC10% OwnerJun 06, 2018 Buy$28.66100,0002,865,7163,031,151Jun 08, 2018, 04:07 PM
Manning Paul BDirectorJun 07, 2018 Buy$27.6910,000276,93412,487,823Jun 08, 2018, 08:17 AM
Manning Paul BDirectorJun 06, 2018 Buy$28.8517,000490,45012,477,823Jun 08, 2018, 08:17 AM
Goldman Steven M.DirectorJun 06, 2018 Option Exercise$7.3211,00080,520118,169Jun 07, 2018, 08:53 PM
PERCEPTIVE ADVISORS LLC10% OwnerJun 05, 2018 Buy$25.99100,0002,598,6222,931,151Jun 07, 2018, 04:29 PM
PERCEPTIVE ADVISORS LLC10% OwnerJun 04, 2018 Buy$25.0710,000250,7002,831,151Jun 06, 2018, 04:24 PM
Goldman Steven M.DirectorJun 05, 2018 Buy$26.4115,000396,150107,169Jun 06, 2018, 08:04 AM
Manning Paul BDirectorJun 05, 2018 Buy$26.51100,0002,651,18812,460,823Jun 06, 2018, 08:03 AM
Manning Paul BDirectorJun 04, 2018 Buy$24.4520,000489,01412,360,823Jun 06, 2018, 08:03 AM
Sapir AlexPresident & CEODec 22, 2017 Option Exercise$3.7326,80999,99846,909Dec 27, 2017, 04:32 PM
Manning Paul BDirectorAug 15, 2017 Buy$21.6220,870451,289120,870Aug 17, 2017, 07:01 PM
Manning Paul BDirectorAug 16, 2017 Buy$25.125,000125,578125,870Aug 17, 2017, 07:01 PM
Goldman Steven M.DirectorAug 15, 2017 Buy$22.2320,169448,38292,169Aug 17, 2017, 07:00 PM
Goldman Steven M.DirectorJul 05, 2017 Buy$19.645,00098,2005,000Aug 17, 2017, 06:58 PM
Manning Paul BDirectorJul 05, 2017 Buy$17.0050,000850,0001,783,226Jul 07, 2017, 06:50 AM
Manning Paul BDirectorJul 05, 2017 Buy$17.00100,0001,700,000100,000Jul 07, 2017, 06:50 AM
ALLEN LEE F MD PhDChief Medical OfficerJul 05, 2017 Buy$17.003,50059,5003,500Jul 07, 2017, 06:48 AM
Laliberte KevinSr. VP, Product DevelopmentJul 05, 2017 Buy$17.006,200105,4006,200Jul 07, 2017, 06:47 AM
JEFFS ROGERDirectorJul 05, 2017 Buy$17.0031,400533,80031,400Jul 07, 2017, 06:46 AM
Goldman Steven M.DirectorJul 05, 2017 Buy$17.9472,0001,291,50072,000Jul 07, 2017, 06:45 AM
Sapir AlexPresident & CEOJul 05, 2017 Buy$17.0020,100341,70020,100Jul 07, 2017, 06:44 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Stalfort SeanDirector11/12/201917,480,788
Manning Paul BDirector11/12/201949,038,715
Manning Paul BDirector11/12/2019356,922,940
ZACCARDELLI DAVIDPresident & CEO10/01/2019147,172
ALLEN LEE F MD PhDChief Medical Officer09/30/201927,384
Hahn Mark WChief Financial Officer09/30/201921,700
Hoitt JasonChief Commercial Officer09/30/201966,836
Laliberte KevinSr. VP, Product Development09/30/2019103,488
Laliberte KevinSr. VP, Product Development09/25/201962,000
Manning Paul BDirector08/09/2019445,344
Laliberte KevinSr. VP, Product Development07/31/201922,182
Hoitt JasonChief Commercial Officer07/15/2019115,664
PERCEPTIVE ADVISORS LLC10% Owner07/09/2019495,543
PERCEPTIVE ADVISORS LLC10% Owner07/11/2019715,410
PERCEPTIVE ADVISORS LLC10% Owner07/10/2019208,659
PERCEPTIVE ADVISORS LLC10% Owner07/05/2019823,000
PERCEPTIVE ADVISORS LLC10% Owner07/03/201928,422
PERCEPTIVE ADVISORS LLC10% Owner07/02/201911,540
PERCEPTIVE ADVISORS LLC10% Owner07/01/2019258,043
ZACCARDELLI DAVIDPresident & CEO07/02/2019166,608
Hahn Mark WChief Financial Officer07/01/201921,893
JEFFS ROGERDirector07/01/201918,534
Laliberte KevinSr. VP, Product Development07/01/201916,876
ALLEN LEE F MD PhDChief Medical Officer07/01/201927,770
Hoitt JasonChief Commercial Officer06/28/201932,963
PERCEPTIVE ADVISORS LLC10% Owner06/28/20191,417,085
PERCEPTIVE ADVISORS LLC10% Owner06/27/20194,286,124
Goldman Steven M.Director06/26/201914,511
Goldman Steven M.Director06/20/201914,509
Goldman Steven M.Director05/13/201926,850
Goldman Steven M.Director01/02/201933,548
Hoitt JasonChief Commercial Officer04/08/201920,934
Manning Paul BDirector03/07/2019508,640
JEFFS ROGERDirector12/20/20187,306
JEFFS ROGERDirector12/19/2018179,329
ZACCARDELLI DAVIDPresident & CEO12/20/201860,700
Manning Paul BDirector12/21/2018832,050
Stalfort SeanDirector12/20/2018194,060
Hahn Mark WChief Financial Officer12/19/201815,700
Manning Paul BDirector12/20/20181,645,113
Sapir AlexPresident & CEO08/14/2018495,411
Goldman Steven M.Director08/13/201813,410
Goldman Steven M.Director06/21/2018151,100
PERCEPTIVE ADVISORS LLC10% Owner06/11/2018578,424
PERCEPTIVE ADVISORS LLC10% Owner06/08/2018716,200
PERCEPTIVE ADVISORS LLC10% Owner06/07/20181,409,154
PERCEPTIVE ADVISORS LLC10% Owner06/06/20182,865,716
Manning Paul BDirector06/07/2018276,934
Manning Paul BDirector06/06/2018490,450
Goldman Steven M.Director06/06/201880,520
PERCEPTIVE ADVISORS LLC10% Owner06/05/20182,598,622
PERCEPTIVE ADVISORS LLC10% Owner06/04/2018250,700
Goldman Steven M.Director06/05/2018396,150
Manning Paul BDirector06/05/20182,651,188
Manning Paul BDirector06/04/2018489,014
Sapir AlexPresident & CEO12/22/201799,998
Manning Paul BDirector08/15/2017451,289
Manning Paul BDirector08/16/2017125,578
Goldman Steven M.Director08/15/2017448,382
Goldman Steven M.Director07/05/201798,200
Manning Paul BDirector07/05/2017850,000
Manning Paul BDirector07/05/20171,700,000
ALLEN LEE F MD PhDChief Medical Officer07/05/201759,500
Laliberte KevinSr. VP, Product Development07/05/2017105,400
JEFFS ROGERDirector07/05/2017533,800
Goldman Steven M.Director07/05/20171,291,500
Sapir AlexPresident & CEO07/05/2017341,700
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR DOVA PHARMACEUTICALS, INC.
LOADING...